23 hour or Outpatie atient nt ASC outpatient Rehab Patients - - PowerPoint PPT Presentation

23 hour or outpatie atient nt asc
SMART_READER_LITE
LIVE PREVIEW

23 hour or Outpatie atient nt ASC outpatient Rehab Patients - - PowerPoint PPT Presentation

Inpatient Hospital Hospital Hospital Inpatient Surgery Day 1 Day 2 Day 3 Rehab 23 hour or Outpatie atient nt ASC outpatient Rehab Patients dont need prolonged hospitalization More functional Pain control Blood


slide-1
SLIDE 1
slide-2
SLIDE 2

Inpatient Surgery Hospital Day 1 Hospital Day 2 Hospital Day 3 Inpatient Rehab

ASC 23 hour or

  • utpatient

Outpatie atient nt Rehab

slide-3
SLIDE 3

 Patients don’t need prolonged

hospitalization

  • More functional
  • Pain control
  • Blood management

 Patient centered approach  Cost effective

slide-4
SLIDE 4

 Organization  Patient selection  Preparation  Execution

slide-5
SLIDE 5

 ASC director  Insurance issues  Materials management/Vendors  PACU/23 hour stay  Rehabilitation

slide-6
SLIDE 6

 Appropriate total joint candidate  Insurance  Medical clearance  Communication and Education  Motivated to improve  Important decision in the early

cases performed at ASC

slide-7
SLIDE 7

 Patient education is paramount!  Prehab  Medical staff education

  • Anesthesia
  • Nurses
  • Surgical staff
  • Therapist
slide-8
SLIDE 8

 Instruments

  • Sterilization
  • Multiple sets
  • Power equipment
  • Bed set-up
  • Fluoroscopy

 Implants

slide-9
SLIDE 9

 Pain management

  • Preoperative
  • Intraoperative
  • Postoperative

 Home equipment  Rehab

slide-10
SLIDE 10

 Hospital back-up plans

slide-11
SLIDE 11

 Simulate first  Team approach

  • Anesthesia
  • Nurses
  • Therapists
  • Surgeon
  • Surgical staff
slide-12
SLIDE 12

 Dr. Domb

  • Performs Hip

Arthroscopy and THA at ASC

  • Two techniques

 Traditional  MAKO robotic-assisted technology

slide-13
SLIDE 13

 Patient Selection!

  • Assessment of pain

prior to procedure

  • Evaluation of

comorbid conditions and current health status

  • Insurance pre-

approval process

  • Research evaluating

clinical outcomes

slide-14
SLIDE 14

Hip Arthroscopy: What is Treatable Today?

slide-15
SLIDE 15

 Labral tears  Femoro-acetabular impingement (FAI)  Instability  Borderline Dysplasia  Gluteus Medius Tears  Snapping Hip

slide-16
SLIDE 16

Labral Base Refixation in the Hip: Rationale and Technique for an Anatomic Approach to Labral Repair

Robert Fry, M.D. Benjamin Domb, M.D.

slide-17
SLIDE 17

Simple Stitch

Labral l Base e St Stit itch

  • Labrum everted + bunched
  • No contact with femoral

head

  • No suction seal

1. Triangular shape preserved 2. Restore transitional zone 3. Restore suction seal

slide-18
SLIDE 18
slide-19
SLIDE 19

Domb, Giordano, Philippon Arthroscopy 2013

slide-20
SLIDE 20
slide-21
SLIDE 21

Large Full Thickness Tear Double-Row Suture-Bridge Repair

Tendon Trochant er

slide-22
SLIDE 22
  • 3D virtual pre-op implant planning
  • Navigated stem placement
  • Haptically guided acetabular

preparation & placement

  • Combined Version
  • Hip Length
  • Hip Offset
slide-23
SLIDE 23

 More accurate

positioning of implants with:

  • Robotic arm guidance
  • 3-D visual feedback
  • Real-time data

 Decreased likelihood

  • f mechanical failure

 Improved outcomes

slide-24
SLIDE 24

(scree creen shot – femur/ r/tibia) ibia)

  • 1. Plan & Broach

Femoral Stem

  • 2. Combined Anteversion

Assessment

  • 3. Pre-operative

Cup Planning

  • 4. Robotic Cup

Placement

  • 5. Quantified Surgical Report

2 1 m 37°

slide-25
SLIDE 25

 Inputs:

  • Patient CT Scan
  • 3D Bone Models
  • Size of Implant
  • Center of Rotation
  • Inclination
  • Version
  • Native Femoral

Version

slide-26
SLIDE 26

Inputs: → 3D Templating → Neck length is selected based on patient anatomy Outputs: ← Planned neck resection plane ← Complete visualization of the planned implant positions ← Measurement of final broach position

slide-27
SLIDE 27
  • Femoral version is

difficult to control in a cementless, broach-

  • nly, system
  • Therefore, the

planned cup version is updated intra-

  • peratively based on

the femoral version achieved during broaching

(Dorr, CORR 2009) (Jolles, JoA 2002)

slide-28
SLIDE 28

Software Provides: ← Complete visualization of the planned implant positions ← Predicted hip length ← Predicted offset

slide-29
SLIDE 29

Resected bone 0.5mm 1mm

  • 1. Visual Feedback:

Green/White/Red

  • 2. Tactile Feedback:

Haptic Stiffness (0.5-1mm)

  • 3. Audible Feedback:

Beeping (0.5-1mm)

slide-30
SLIDE 30
  • Robot haptically

guides both reaming & impaction

  • Real-time

numeric & graphical representation of the progression of reaming & impaction

slide-31
SLIDE 31

Conical Haptic

  • Initial Reaming

Line Haptic

  • Reaming, Impaction
slide-32
SLIDE 32

 Continued assessment of THA outcomes

based on:

  • Component placement
  • Leg length discrepancy
  • Global offset
  • Predictive vs actual positioning
  • Comparative studies or various approaches

 Published articles in:

  • CORR
  • Journal of Arthroplasty
  • Orthopedics
slide-33
SLIDE 33

 Analgesia in THA

involves multimodal analgesia

 Postoperative opioid-

related events can slow recovery and increase patients’ length of stay

 Long-acting local

anesthetics can reduce early postoperative pain at the surgical site

slide-34
SLIDE 34

 Decreasing opioid

use while maintaining adequate pain control could reduce:

  • opioid-related events
  • increase patient time

to first ambulation

  • decrease length of

stay

slide-35
SLIDE 35

 Research comparing the effectiveness of liposomal

bupivacaine with bupivacaine following total hip arthroplasty.

 Study group= 27 consecutive patients who received liposomal

bupivacaine

 Control group=previous 30 consecutive patients who received

bupivacaine alone

  • All patients received a combination of celecoxib 400 mg PO,

pregabalin 75 mg PO and 1gm of IV acetaminophen prior to procedure

  • The study group received 20 cc of liposomal bupivacaine,

combined with 40 cc 0.25% bupivacaine HCl with epinephrine and 20 cc of preservative free normal saline

  • The control group received 60 ml of 0.25% bupivacaine HCl with

epinephrine

slide-36
SLIDE 36

 The study group median length of stay was 1.9 days;

the control group median length of stay was 2.5 days (p = 0.05).

 Both groups had average VAS scores of 2.8 during

the first 24 hours after surgery and 3.3 during the time frame of 24 to 48 hours after surgery

 The study group average morphine equivalent use

during the first 24 hours after surgery was 24.0 mg, and the control group 53.4 mg (p <0.05)

 From 24 to 48 hours from surgery, the average

morphine equivalent use in the study group was 41.1 mg, and the control group 64.9 mg,

slide-37
SLIDE 37

 Liposomal bupivacaine administration during

THA appears:

  • to decrease the need for opioid use post operatively
  • to decrease length of stay

 The results of this study justify the need for

a well-designed RCT utilizing liposomal bupivacaine as part of multimodal analgesia during THA

  • RCT started September 2014
  • 11 patients enrolled to date
slide-38
SLIDE 38

 Patient preparation  Simulation in hospital  Staff preparation  Team approach  Good experiences will generate

more opportunities

slide-39
SLIDE 39

Questions?